Mostrar el registro sencillo del ítem

Eosinopenia en pacientes con síndrome de respuesta inflamatoria sistémica, características operativas y asociación con su calidad pronóstica

dc.contributor.advisorPérez, Carlos
dc.contributor.advisorGranados, Carlos Eduardo
dc.contributor.authorOrozco Araujo, Silvana
dc.contributor.authorGuerra Malaver, Nelcy Teresa
dc.date.accessioned2012-03-06T20:06:43Z
dc.date.available2012-03-06T20:06:43Z
dc.date.created2011
dc.date.issued2012-03-06
dc.identifier.citationWintrobe, M, Wintrobe’s Clinical Hematology, Lippincott williams y wilkins, Philadelphia, 12th edition, 2009
dc.identifier.citationFauci A y cols, Harrison’s principles of internal medicine, McGraw-Hill”s, 17th edition, 2008
dc.identifier.citationSanderson CJ. Interleukin-5, eosinophils, and disease. Blood. 79, 3101- 3109, 1992
dc.identifier.citationE Cecchini y cols, Infectologia y Enfermedades Infecciosas, Futuro, 2007
dc.identifier.citationAbbas A, Lichtman, Inmunologia cellular y molecular 6 ed, Elsevier, 2009
dc.identifier.citationMorgan JE, Beeson PB. Experimental observations on the eosinopenia induced by acute infection. Br J Exp Pathol, 52(2):214–220, 1971.
dc.identifier.citationWeber H, A quantitative study of eosinopenia and other stress indices. The Journal of sports medicine and physical fitness, 11/1(12-23), March 1971
dc.identifier.citationLópez-Osuna M, Cárdenas G, Increased susceptibility to experimental amebic abscess of the liver in gerbils (Meriones unguiculatus) with induced eosinopenia. Archives of medical research, v31/4, July 2000
dc.identifier.citationRoberts WC, Liegler DG, Carbone PP. Endomyocardial disease and eosinophilia. A clinical and pathologic spectrum. Am J Med. Jan;46(1):28–42. 1969
dc.identifier.citationWeiner HA, Morkovin D. Circulating blood eosinophils in acute infectious disease and the eosinopenic response. Am J Med.;13(1):58–72, 1952
dc.identifier.citationTartakovskiĭ MB, Kanter IR, Syndromes associated with eosinopenia. Freeman GL Allergy, vol./is. 53/3(331-3), 1998
dc.identifier.citationS D Burdette, M A Parilo, Systemic Inflammatory Response Syndrome, Critical Care, Medical College of Pennsylvania Hahnemann University
dc.identifier.citationRangel-Fausto, Pittet D, Costigan M. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 273:117-123, 1995
dc.identifier.citationBone RC. Systemic inflammatory response syndrome: a unifying concept of systemic inflammation. Sepsis and Multiorgan Failure. Philadelphia, 1-10, 1997.
dc.identifier.citationBone RC, Balk RA, Cerra FC, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest.;101:1644-1655, 1992
dc.identifier.citationDavies MG, Hagen PO. Systemic inflammatory response syndrome. Br J Surg.;84(7):920-35, Jul 1997
dc.identifier.citationBaue AE. Multiple organ failure, multiple organ dysfunction syndrome, and systemic inflammatory response syndrome. Why no magic bullets?. Arch Sur;132(7):703, Jul 1997
dc.identifier.citationBone RC, Balk RA, Cerra FC, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 101:1644-1655, 1992
dc.identifier.citationEarly goal-directed therapy in the treatment of severe sepsis and septic chock. N Engl J Med, Vol. 345, No. 19 November 8, 2001
dc.identifier.citationShapiro N, Howell MD, Bates DW. The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med. 48:583-590, 2006
dc.identifier.citationWhitcomb C, Acute Pancreatitis, N Engl J Med; 354:2142-50, 2006
dc.identifier.citationHirai S. Systemic inflammatory response syndrome after cardiac surgery under cardiopulmonary bypass. Ann Thorac Cardiovasc Surg. 9:365- 370, 2003
dc.identifier.citationWolf I, Mouallem M, Rath S. Clopidogrel-induced systemic inflammatory response syndrome. Mayo Clin Proc. 78:618-620, 2003
dc.identifier.citationThomas Korn, Vijay K. Kuchroo, Mechanisms of Disease Interleukin-17 and Type 17 Helper T Cells Pierre Miossec, N Engl J Med, 361:888- 98, 2009
dc.identifier.citationL Williams, Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin, Critical Care Medicine Vol 28, 8, 2000
dc.identifier.citationBass DA. Behavior of eosinophil leukocytes in acute inflammation. Eosinophil dynamics during acute inflammation. J Clin Invest. Oct;56(4):870–875, 1975
dc.identifier.citationBass D and cols, Eosinopenia of Acute Infection, J clin Invest, V 65, 1265-1271, 1980
dc.identifier.citationHo kM, A comparison of eosinopenia and C-reactive protein as a marker of bloodstream infections in critically ill patients: a case control study. Anaesthesia and intensive care, vol./is. 37/3(450-6), May 2009
dc.identifier.citationHenry Wl Jr, Oliner L, Relationship between actions of adrenocortical steroids and adrenomedullary hormones in the production of eosinopenia. Am J Physiol. 174(3):455–458, 1953
dc.identifier.citationHolzmann H, Korting GW, On the effect of testosterone on the eosinophil count and dexamethasone-induced eosinopenia in man, Archiv fur klinische und experimentelle Dermatologie,(523-30), 1960
dc.identifier.citationHolzmann H, Korting GW, On differences in eosinopenia caused by dexamethasone in dependence on the method of administration. Archiv fur klinische und experimentelle Dermatologie,(418-26), 1960
dc.identifier.citationMorandi L and cols, The mechanism of insulin eosinopenia, vol./is. 35/20, 1957
dc.identifier.citationMorandi L and cols, Mechanism of adrenalin- and insulin-induced eosinopenia. Helvetica medica acta, vol./is. 24/4(482-7), October 1957
dc.identifier.citationDellinger P, Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, Critical Care Medicine , Vol 36, Issue 1, January 2008
dc.identifier.citationAnil Potti, and Raymond A. Smego, Utility of Eosinophil Count as Predictor of Bacteremia,Clin Infect Dis, Vol 38, 460-461,1971
dc.identifier.citationGil H and cols, Value of eosinopenia in inflammatory disorders: an “old’ marker revisited, Rev med Interne, 24(7), 431-5, 2003
dc.identifier.citationAlkhalil M and cols, Eosinopenia as a marker of mortality and length of stay in patients admitted with exacerbations of chronic obstructive pulmonary disease.Holland M, Respirology, (15) 165-167, 2010
dc.identifier.citationStamatis P, Angelo V et al. Fever of unknown origin: Discrimination between infectious and non infectious causes. European Journal of Internal Medicine. 21 137-143, 2010
dc.identifier.citationHamid Shaaban and cols, Eosinopenia: is it a good marker of sepsis in comparison to procalcitonin and C-reative protein levels for patients to a critical care unit in an urban hospital?, Journal Of critical care, 25, 570-575, 2010
dc.identifier.citationA Smithson, Is eosinopenia a reliable marker of sepsis?, critical care, 13: 409, 2009
dc.identifier.citationMokart D, Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. British journal of anaesthesia, 94(6), 767-73, 2005
dc.identifier.citationIsabel NH, Eosinofilia y parasitosis, Rev chil pediatr, 70 (5), 1999
dc.identifier.citationAbidi K and cols, Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units, Critical Care,12 (2), 1-10, 2008
dc.identifier.citationTrauma prioridades, Sociedad argentina de medicina y cirugia del trauma, editorial panamericana 2002, pag 96
dc.identifier.urihttp://hdl.handle.net/10818/1300
dc.description51 Páginas.
dc.description.abstractEste estudio determina la prevalencia de eosinopenia en SIRS, sus características operativas y su asociación con complicaciones. Se revisaron 335 pacientes con SIRS encontrando una prevalencia de 43,6% de eosinopenia. Los pacientes con SIRS-I con eosinopenia mostraron una mayor frecuencia de requerimiento de soporte ventilatorio (21,5%) y vasopresor (22%) con respecto al grupo de SIRS-I sin eosinopenia. La mortalidad en el grupo con SIRS-NI con eosinopenia fue significativamente mayor (27%) que en el grupo de SIRS sin eosinopenia (16,5%) p0,06. La eosinopenia tiene un bajo rendimiento para ayudar a diferenciar SIRS-I de SIRS-NI, sin embargo existe asociación entre eosinopenia en pacientes con SIRS de cualquier etiología y desenlaces clínicos adversos, tales como mortalidad y necesidad de soporte avanzado.es_CO
dc.language.isospaes_CO
dc.publisherUniversidad de La Sabana
dc.sourceUniversidad de La Sabana
dc.sourceIntellectum Repositorio Universidad de La Sabana
dc.subjectSíndrome de respuesta inflamatoria sistémica-Investigacioneses_CO
dc.subjectEosinopenia-Investigacioneses_CO
dc.titleEosinopenia en pacientes con síndrome de respuesta inflamatoria sistémica, características operativas y asociación con su calidad pronósticaes_CO
dc.typebachelorThesis
dc.publisher.programEspecialización en Medicina Interna
dc.publisher.departmentFacultad de Medicina
dc.identifier.local142363
dc.identifier.localTE00051
dc.type.localTesis de especialización
dc.type.hasVersionpublishedVersion
dc.rights.accessRightsopenAccess
dc.creator.degreeEspecialización en Medicina Interna


Ficheros en el ítem

Thumbnail
Nombre:
Silvana Orozco Araujo.pdf
Tamaño:
380.9Kb
Formato:
PDF
Descripción:
Ver documento en PDF
Ver/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem